Vancouver, British Columbia--(Newsfile Corp. - August 15, 2025) - IAMGOLD Corp. (TSX: IMG) (NYSE: IAG) - With a sharpened focus on Canada and large-scale production targets, Iamgold is nearing completion on its transformative repositioning as Canada's next mid-tier gold champion. The company is poised to significantly increase output and enter a strong free cash flow cycle, all while advancing new growth initiatives aimed at long-term value creation.

Intercorp Financial Services Inc. (NYSE:IFS ) Q2 2025 Earnings Conference Call August 12, 2025 10:00 AM ET Company Participants Carlos Jose Tori Grande - Chief Executive Officer Luis Felipe Castellanos Lopez-Torres - CEO & GM Michela Casassa Ramat - Chief Financial Officer Conference Call Participants Ernesto María Gabilondo Márquez - BofA Securities, Research Division Ivan Peill - Unidentified Company Operator Good morning, and welcome to the Intercorp Financial Services Second Quarter 2025 Conference Call. [Operator Instructions] Please be advised that today's conference call is being recorded.

ESS Tech (GWH) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

The mean of analysts' price targets for The Pennant Group (PNTG) points to a 31.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The mean of analysts' price targets for West Pharmaceutical (WST) points to a 28.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Mettler-Toledo International, Inc. (MTD) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, MTD's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.

The mean of analysts' price targets for Harrow (HROW) points to a 53.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The mean of analysts' price targets for Passage Bio (PASG) points to a 1415.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 25.6% in Ardmore Shipping (ASC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The mean of analysts' price targets for Astria Therapeutics (ATXS) points to a 333.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The consensus price target hints at a 151% upside potential for Tourmaline Bio, Inc. (TRML). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

SAN FRANCISCO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- After investors in SelectQuote (NYSE: SLQT) saw the price of their shares tumble over 19% on May 1, 2025 when the U.S. Department of Justice announced it had intervened in a lawsuit against the company, a securities class action lawsuit, styled Pahlkotter v. SelectQuote, Inc. et al., No. 1:25-cv-06620 (S.D.N.Y.) has been filed. The suit seeks to represent investors who purchased or otherwise acquired SelectQuote securities between September 9, 2020 and May 1, 2025.

SAN FRANCISCO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- On May 6, 2025 investors in BellRing Brands, Inc. (NYSE: BRBR) saw the price of their shares decline about 19% after BellRing announced during its Q2 2025 earnings call that it anticipated Q3 2025 reduction in retailer inventory levels.

Sanofi wins EMA's orphan drug status for rilzabrutinib to treat IgG4-RD, a chronic, immune-mediated rare disease.

CPA posts strong July 2025 traffic, with rising load factor as demand growth outpaces capacity expansion.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.